Disposable NFC Biomarker Patches

Gentag broadly patented in 2004 the use of NFC sensors combined with disposable skin patches and biomarkers. Biomarkers are present in any fluid, including sweat, and can identify a host of health and medical conditions.

This patented technology is covered under broadly issued patents in North America, Asia and Europe.

Molecular-Level Sensors

The detection of minuscule amounts of toxins, proteins, DNA or chemicals is increasingly possible using advanced nano-materials. The Gentag biomarkers platform is covered by 93 issued patents (held in our patent holding company Altivera, LLC). Gentag is working with some of the leaders in microelectronics and biosensors to develop printable cutting-edge molecular-level sensors.

Our genome is constantly interacting with an ever-changing environment, and smartphones can now provide a new interface.

Disposable NFC Lab-on-a-Chip

NFC can be combined with lab-on-a-chip microfluidics technology to create a powerful new platform for on-the-spot diagnostics with cell phones. The technology can be used for advanced protein detection, DNA analyses, or drug delivery.

This technology platform is covered by 31 issued patents.

Disposable NFC Immunoassays

Disposable immunoassays – diagnostic tests for proteins that correspond to specific allergens, infectious diseases, and even cancerous cells – can be combined with custom disposable NFC wireless chips to allow rapid, on-the-go testing using mobile devices. Gentag’s proprietary technology, which is covered by 31 issued patents, will enable the use of printable, battery-less wireless immunoassays that can be read directly with cell phones.

Modular Sensors for Phones

Gentag owns a number of groundbreaking patents covering the uses of interchangeable, person-specific chemical sensor modules in cell phones for threat and allergen detection. Using a patented Gentag “reverse e-nose” technology, a mobile device can be trained to recognize the environmental factors that trigger asthma or an allergic reaction in a given individual, allowing the creation of truly personalized genomic devices.

Contact Gentag for details.